Literature DB >> 16905554

Abnormal myocardial deformation properties in obese, non-hypertensive children: an ambulatory blood pressure monitoring, standard echocardiographic, and strain rate imaging study.

Giovanni Di Salvo1, Giuseppe Pacileo, Emanuele Miraglia Del Giudice, Francesco Natale, Giuseppe Limongelli, Marina Verrengia, Alessandra Rea, Fiorella Fratta, Biagio Castaldi, Antonello D'Andrea, Paolo Calabrò, Tiziana Miele, Filomena Coppola, Maria Giovanna Russo, Pio Caso, Laura Perrone, Raffaele Calabrò.   

Abstract

AIMS: The prevalence of obesity is increasing among children in the developed world. The association of obesity and abnormal cardiac function is still debated. The reported changes may reflect the role of comorbidities that contribute to ventricular dysfunction. Obese children, without arterial hypertension, may be a unique clinical opportunity to evaluate the effect of obesity, per se, on myocardial function, excluding the influence of possible comorbidities. We sought to define the preclinical effects of obesity on the cardiovascular system, of healthy children with excess weight who have no other clinically appreciable cause of heart disease, using the more sensitive ultrasonic-derived strain and strain rate (SR) imaging. METHODS AND
RESULTS: We studied 300 subjects divided into two groups: (i) obese children (Group O: n=150; age, 12+/-3 years); (ii) healthy lean children comparable for age, sex, and pubertal stage (Referents: n=150; mean age, 12+/-3 years). Systolic (SBP) and diastolic blood pressure (DBP), as well as 24 h-SBP and 24 h-DBP were comparable between groups. Left ventricular (LV) mass/height(2.7) was increased (P<0.0001) in Group O (46+/-12 g/m(2.7)) when compared with Referents (31+/-14 gm(2.7)). Standard echocardiographic indices of global systolic function were similar in the two groups. Intima-media thickness measured at the common carotid artery was not significantly different (P=0.4) in obese children (0.46+/-0.09 mm) when compared with Referents (0.45+/-0.07 mm). Obese children showed regional longitudinal peak systolic myocardial deformation properties (SR=-1.4+/-0.7 s(-1)) lower (P<0.0001) than those of Referents (SR=-2.2+/-0.5) in both left and right ventricle. In multivariable analysis, average peak systolic SR was significantly correlated with homeostasis model assessment of insulin resistance (P<0.01; coefficient, 0.02; SE, 0.011), and insulin serum concentration (P<0.01; coefficient, 0.05; SE, 0.023). Average LV peak systolic strain was significantly correlated with body mass index (P=0.0001; coefficient, 0.06; SE, 0.016), LVM/H(2.7) (P=0.006; coefficient, 0.016; SE, 0.018).
CONCLUSIONS: Our study demonstrated that obesity, in absence of hypertension, is associated with significant reduction in systolic myocardial deformation properties already in childhood involving both right and left ventricle. Obesity not only is a risk factor for later cardiovascular disease, but also is associated with contemporaneous and significant impairment of longitudinal myocardial deformation properties.

Entities:  

Mesh:

Year:  2006        PMID: 16905554     DOI: 10.1093/eurheartj/ehl163

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  45 in total

Review 1.  Increased intima-media thickness of the carotid artery in childhood: a systematic review of observational studies.

Authors:  Christophe Lamotte; Catalina Iliescu; Christian Libersa; Frédéric Gottrand
Journal:  Eur J Pediatr       Date:  2010-10-27       Impact factor: 3.183

Review 2.  Echocardiography in the assessment of left ventricular longitudinal systolic function: current methodology and clinical applications.

Authors:  Valerio Zacà; Piercarlo Ballo; Maurizio Galderisi; Sergio Mondillo
Journal:  Heart Fail Rev       Date:  2010-01       Impact factor: 4.214

Review 3.  Cardiac Abnormalities in Youth with Obesity and Type 2 Diabetes.

Authors:  Fida Bacha; Samuel S Gidding
Journal:  Curr Diab Rep       Date:  2016-07       Impact factor: 4.810

4.  Atenolol vs enalapril in young hypertensive patients after successful repair of aortic coarctation.

Authors:  G Di Salvo; B Castaldi; S Gala; L Baldini; F Del Gaizo; F A D'Aiello; A Mormile; A Rea; G Scognamiglio; G Pacileo; S Keating; B M Fadel; L Berrino; A Perna; M G Russo; R Calabrò
Journal:  J Hum Hypertens       Date:  2015-08-20       Impact factor: 3.012

5.  Early ventricular remodeling and dysfunction in obese children and adolescents.

Authors:  Aura A Sanchez; Gautam K Singh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-10

6.  Predictors of mortality in pediatric patients on venoarterial extracorporeal membrane oxygenation.

Authors:  Rajesh Punn; David M Axelrod; Sara Sherman-Levine; Stephen J Roth; Theresa A Tacy
Journal:  Pediatr Crit Care Med       Date:  2014-11       Impact factor: 3.624

7.  Correlation between left ventricular myocardial strain and left ventricular geometry in healthy adults: a cardiovascular magnetic resonance-feature tracking study.

Authors:  Zhen Zhang; Qiaozhi Ma; Lizhen Cao; Zhiwei Zhao; Jun Zhao; Qing Lu; Linan Zeng; Mingzhu Zhang; Gerald M Pohost; Kuncheng Li
Journal:  Int J Cardiovasc Imaging       Date:  2019-08-12       Impact factor: 2.357

Review 8.  Intima-media thickness measurements in children with cardiovascular risk factors.

Authors:  Mieczysław Litwin; Anna Niemirska
Journal:  Pediatr Nephrol       Date:  2008-09-11       Impact factor: 3.714

9.  Effect of obesity on left ventricular longitudinal myocardial strain by speckle tracking echocardiography in children and adolescents.

Authors:  Ayşe Esin Kibar; Feyza Ayşenur Pac; İbrahim Ece; Mehmet Burhan Oflaz; Şevket Ballı; Veysel Nejat Bas; Zehra Aycan
Journal:  Balkan Med J       Date:  2015-01-01       Impact factor: 2.021

10.  Evaluation of left atrial functions by color tissue Doppler imaging in adults with body mass indexes >or=30 kg/m(2) versus those <30 kg/m (2).

Authors:  Okan Gulel; Serkan Yuksel; Korhan Soylu; Ozgur Kaplan; Ozcan Yilmaz; Hakki Kahraman; Mahmut Sahin
Journal:  Int J Cardiovasc Imaging       Date:  2008-12-25       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.